31994R2701

English (current language)
Language
My EUR-Lex
- My EUR-Lex
- Sign in
- Register
- My recent searches (0)

This document is an excerpt from the EUR-Lex website

Search tips

Need more search options? Use the Advanced search

Document 31994R2701

Commission Regulation (EC) No 2701/94 of 7 November 1994 amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance)

OJ L 287, 8.11.1994, p. 7–17 (ES, DA, DE, EL, EN, FR, IT, NL, PT)
Special edition in Finnish: Chapter 03 Volume 062 P. 179 - 189
Special edition in Swedish: Chapter 03 Volume 062 P. 179 - 189
Special edition in Czech: Chapter 03 Volume 016 P. 476 - 486
Special edition in Estonian: Chapter 03 Volume 016 P. 476 - 486
Special edition in Latvian: Chapter 03 Volume 016 P. 476 - 486
Special edition in Lithuanian: Chapter 03 Volume 016 P. 476 - 486
Special edition in Hungarian Chapter 03 Volume 016 P. 476 - 486
Special edition in Maltese: Chapter 03 Volume 016 P. 476 - 486
Special edition in Polish: Chapter 03 Volume 016 P. 476 - 486
Special edition in Slovak: Chapter 03 Volume 016 P. 476 - 486
Special edition in Slovene: Chapter 03 Volume 016 P. 476 - 486
Special edition in Bulgarian: Chapter 03 Volume 016 P. 8 - 18
Special edition in Romanian: Chapter 03 Volume 016 P. 8 - 18

No longer in force, Date of end of validity: 05/07/2009; Arna aisghairm go hintuigthe ag 32009R0470

ELI: http://data.europa.eu/eli/reg/1994/2701/oj

Languages, formats and link to OJ

HTML

PDF

Official Journal

Multilingual display

Text

8.11.1994

Official Journal of the European Communities

L 287/7

COMMISSION REGULATION (EC) NO 2701/94

of 7 November 1994

amending Annexes I, II, III and IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

Having regard to the Treaty establishing the European Community,

Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (1), as last amended by Commission Regulation (EC) No 1430/94 (2), and in particular Articles 6, 7 and 8 thereof,

Whereas, since the adoption of the Regulation, the Annexes have been amended a number of times; whereas, by reason of their number, their complexity and their dispersal among various Official Journals of the European Communities, the texts are difficult to use and thus lack the clarity which should be an essential feature of all legislation; whereas, they should therefore be consolidated; whereas on the same occasion the name or chemical description of some compounds should be rectified or made more precise and certain material errors should be corrected;

Whereas the measures provided for in this Regulation are in accordance with the opinion of the Committee for the adaptation to technical progress of directives on the removal of technical barriers to trade in the veterinary medicinal products sector,

HAS ADOPTED THIS REGULATION:

Article 1

Annexes I, II, III and IV to Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto.

Article 2

This Regulation shall enter into force on the 60th day following its publication in the Official Journal of the European Communities.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 7 November 1994.

For the Commission

Martin BANGEMANN

Member of the Commission

(1) OJ No L 224, 18. 8. 1990, p. 1.

(2) OJ No L 156, 23. 6. 1994, p. 6.

ANNEX

‘

ANNEX I

List of pharmacologically active substances for which maximum residue limits have been fixed

Anti-infectious agents

1.1.

Chemotherapeutics

1.1.1.

Sulfonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
All substances belonging to the sulfonamide group	Parent drug	All food producing species	100 μg/kg	Muscle, liver, kidney, fat	The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

1.2.

Antibiotics

1.2.1.

Penicillins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.1.1.

Benzylpenicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

4 μg/kg

Milk

1.2.1.2.

Ampicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

4 μg/kg

Milk

1.2.1.3.

Amoxicillin

All food producing species

50 μg/kg

Muscle, liver, kidney, fat

4 μg/kg

Milk

1.2.1.4.

Oxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

30 μg/kg

Milk

1.2.1.5.

Cloxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

30 μg/kg

Milk

1.2.1.6.

Dicloxacillin

All food producing species

300 μg/kg

Muscle, liver, kidney, fat

30 μg/kg

Milk

1.2.2.

Cephalosporins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.2.1.

Cefquinome

Bovine

200 μg/kg

Kidney

100 μg/kg

Liver

50 μg/kg

Muscle

50 μg/kg

Fat

1.2.3.

Quinolones

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.3.1.

Enrofloxacin

Sum of enrofloxacin and ciprofloxacin

Bovine, porcine, poultry

30 μg/kg

Muscle, liver, kidney

1.2.4.

Macrolides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
1.2.4.1. Tilmicosin	Tilmicosin	Bovine	1 000 μg/kg	Liver, kidney
1.2.4.1. Tilmicosin	Tilmicosin	Bovine	50 μg/kg	Muscle, fat

Antiparasitic agents

2.1.

Agents acting against endoparasites

2.1.1.

Avermectins

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.1.1.

Ivermectin

22,23- Dihydroavermectin B1a

Bovine

100 μg/kg

Liver

40 μg/kg

Fat

Porcine

15 μg/kg

Liver

Ovine

20 μg/kg

Fat

Equidae

2.1.1.2.

Abamectin

Avermectin B1a

Bovine

20 μg/kg

Liver

10 μg/kg

Fat

2.1.1.3.

Doramectin

Bovine

15 μg/kg

Liver

25 μg/kg

Fat

2.1.2

Salicylanilides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.2.1.

Closantel

Bovine

1 000 μg/kg

Muscle, liver

3 000 μg/kg

Kidney, fat

Ovine

1 500 μg/kg

Muscle, liver

5 000 μg/kg

Kidney, fat

2 000 μg/kg

ANNEX II

List of substances not subject to maximum residue limits

Inorganic chemicals

Pharmacologically active substance(s)

Animal species

Other provisions

1.1.	Hydrogen peroxide

Fish

1.2.

Sulphur

Bovine

Porcine

Ovine

Caprine

Equidae

1.3.

Iodine and iodine inorganic compounds including:

—	Sodium and potassium — iodide

—	Sodium and potassium — iodate

—	Iodophors including polyvinylpyrrolidone — iodine

All food producing species

1.4.	Sodium chlorite

Bovine

For tropical use only

Organic compounds

Pharmacologically active substance(s)

Animal species

Others provisions

2.1.	Etiproston tromethamine

Bovine

Porcine

2.2.	Ketanserin tartrate

Equidae

2.3.	Fertirelin acetate

Bovine

2.4.	Human menopausal urinary gonadotrophin

Bovine

2.5.	Lactic acid

All food producing species

2.6.

Melatonin

Ovine

Caprine

2.7.

Iodine organic compounds

—

Iodoform

All food producing species

2.8.	Acetyl cysteine

All food producing species

ANNEX III

List of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed

Anti-infectious agents

1.1.

Chemotherapeutics

1.1.1.

Sulfonamides

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
All substances belonging to the sulfonamide group	Parent drug	Bovine, ovine, caprine	100 μg/kg	Milk	Provisional MRL expires on 1. 1. 1996. The combined total residues of all substances within the sulfonamide group should not exceed 100 μg/kg

1.1.2.

Diamino pyrimidine derivates

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.2.1.

Trimethoprim

All food producing species

50 μg/kg

Muscle, liver, kidney, fat, milk

Provisional MRL expires on 1. 1. 1996

1.1.3.

Nitrofurans

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.3.1.

Furazolidone

All residues with intact 5-nitro structure

All food producing species

5 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 7. 1995

1.1.4.

Nitroimidazoles

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.1.4.1.

Dimetridazole

All residues with intact nitroimidazole structure

All food producing species

10 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 1. 1995

1.2.

Antibiotics

1.2.1.

Tetracyclines

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
All substances belonging to the tetracycline group	Parent drug	All food producing species	600 μg/kg	Kidney	Provisional MRLs expire on 1. 1. 1996. The combined total residues of all substances within the tetracycline group should not exceed the limits indicated
			300 μg/kg	Liver
			200 μg/kg	Eggs
			100 μg/kg	Muscle
			100 μg/kg	Milk

1.2.2.

Macrolides

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

1.2.2.1.

Spiramycin

Bovine, porcine

300 μg/kg

Liver,

Provisional MRLs expire on 1. 7. 1995. The MRLs for liver, kidney and muscle apply to both the bovine and porcine species

200 μg/kg

Kidney,

50 μg/kg

Muscle

Bovine

150 μg/kg

Milk

1.2.2.2.

Tylosin

Bovine

100 μg/kg

Muscle, liver, kidney

Provisional MRLs expire on 1. 7. 1995

Porcine

Poultry

Bovine

50 μg/kg

Milk

1.2.3.

Thiamphenicol and related compounds

Pharmacologically active substance(s)

Market residue

Animal species

MRLs

Target tissues

Other provisions

1.2.3.1.

Thiamphenicol

Bovine

Poultry

40 μg/kg

Muscle, liver, kidney, fat

Provisional MRL expires on 1. 1. 1996

Antiparasitic agents

2.1.

Agents acting against endo-parasites

2.1.1.

Benzimidazoles and pro-benzimidazoles

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.1.1.

Febantel

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.2.

Fenbendazole

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.3.

Oxfendazole

Combined residues of oxfendazole, oxfendazole sulfone and fenbendazole

All food producing species

1 000 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995. The MRLs cover all residues of febantel, fenbendazole and oxfendazole

10 μg/kg

Muscle, kidney, fat

10 μg/kg

Milk

2.1.1.4.

Albendazole

Sum of albendazole and metabolites which are measured as 2-amino-benzimidazole sulphone

Bovine

100 μg/kg

Muscle, fat, milk,

Provisional MRLs expire on 1. 1. 1996

Ovine

500 μg/kg

Kidney

1 000 μg/kg

Liver

2.1.1.5.

Thiabendazole

Sum of thiabendazole and 5-hydroxythiabendazole

Bovine

100 μg/kg

Muscle, liver, kidney, fat, milk

Provisional MRLs expire on 1. 1. 1996

Ovine

Caprine

2.1.1.6.

Triclabendazole

Sum of extractable residues that may be oxidized to ketotriclabendazole

Bovine

150 μg/kg

Muscle, liver, kidney

Provisional MRLs expire on 1. 7. 1995

Ovine

50 μg/kg

Fat

2.1.1.7.

Flubendazole

Poultry

500 μg/kg

Liver,

Provisional MRLs expire on 1. 1. 1996

Game birds

200 μg/kg

Muscle,

400 μg/kg

Eggs

Porcine

10 μg/kg

Muscle, liver, kidney, fat

2.1.1.8.

Oxibendazole

Bovine

Ovine

100 μg/kg

Muscle, liver, kidney, fat

Provisional MRLs expire on 1. 1. 1996

50 μg/kg

Milk

Porcine

Equidae

100 μg/kg

Muscle, liver, kidney, fat

2.1.2.

Tetra-hydro-imidazoles (imidazolthiazoles)

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.1.2.1.

Levamisole

All food producing species

10 μg/kg

Musle, liver, kidney, fat, milk

Provisional MRL expires on 1. 1. 1995

2.2.

Agents acting against ectoparasites

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

2.2.1.

Amitraz

Sum of amitraz and metabolites which are measured as 2,4-dimethylaniline

Porcine

50 μg/kg

Muscle

Provisional MRLs expire on 1. 7. 1996.

200 μg/kg

Kidney, liver

Agents acting on the nervous system

3.1.

Agents acting on the central nervous system

3.1.1.

Butyrophenone tranquilizers

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

3.1.1.1.

Azaperone

Azaperol

All food producing species

100 μg/kg

Kidney

Provisional MRLs expire on 1. 1. 1996

50 μg/kg1

Liver, muscle, fat

3.2.

Agents acting on the autonomic nervous system

3.2.1.

Anti-adrenergics

Pharmacologically active substance(s)

Marker residue

Animal species

MRLs

Target tissues

Other provisions

3.2.1.1.

Carazolol

All food producing species

30 μg/kg

Liver

Provisional MRLs expire on 1. 7. 1995

5 μg/kg

Kidney, muscle, fat

ANNEX IV

List of pharmacologically active substances for which no maximum levels can be fixed

1.	Nitrofurans, except furazolidone (see Annex III)

2.	Ronidazole

Dapsone

4.	Chloramphenicol

’

Top